Appeal 2007-3216
Application 10/271,433
B2. Brown-Skrobot states: “there is a need to find a douche composition
which is able to combat the production of TSST-1 by Staphylococcus aureus
within the vaginal cavity” (Brown-Skrobot, at col. 3, ll. 48-50).
B3. Brown-Skrobot describes a douche composition comprising mono or
diesters of polyhydric aliphatic alcohols (e.g. glyceryl monolaurate) that is
able to combat the production of TSST-1 by Staphylococcus aureus (a
Gram-positive bacteria) within the vaginal cavity (Brown-Skrobot, at
Abstract; col. 3, ll. 54-67; col. 5, 1l. 5-7 and 40-48; col. 6, ll. 12-23; see
Answer 3).
Mitra
M1. Mitra describes topical moisturizing wipes for treating microbial
infections (Mitra, at col. 2, ll. 16-19).
M2. The wipes can comprise effective amounts of antimicrobial compounds
(Mitra, at col. 2, ll. 25-29).
M3. Mitra lists various antimicrobial compounds that are described as being
effective against various human and animal pathogens, including
Staphylococcus aureus (Mitra, at col. 3, ll. 14-16; Answer 4).
M4. Hexachlorophene (“2-2’-dihydroxy-3,3’,5,5’,6,6’-
hexachlorodiphenylmethane”) is listed as a suitable antimicrobial agent
(Mitra, at col. 3, l. 29; Answer 4) for its topical wipes.
M5. The wipes can be used for “treatment of dry membranous tissue . . .
and healthy membranous tissue” (Mitra, at col. 2, ll. 34-39).
M6. “For treatment, the wipe composition is applied to the mucosal skin via
topical application of a safe and effective amount of composition to treat an
existing fungal, microbial or protozoal growth” (Mitra, at col. 10, ll. 52-55).
4
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: September 9, 2013